{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-24-000113","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.679164+00:00","generated_at":"2026-05-30T09:26:56.766894+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stryker Q3 beats: adj EPS $2.87 (+16.7%), sales $5.5B (+11.5% organic), raises FY guidance","bullets":["Reported net sales $5.5B, +11.9% reported, +11.5% organic; adjusted EPS $2.87, +16.7%.","Adjusted operating margin expanded 130bps to 24.7%.","MedSurg & Neurotechnology organic sales +12.7%; Orthopaedics & Spine +9.7%.","FY2024 guidance raised: organic sales growth 9.5%-10.0%, adjusted EPS $12.00-$12.10.","CEO cites product innovation and acquisitions as growth drivers."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-24-000113","json":"https://secwatch.observer/filing/0000310764-24-000113.json","markdown":"https://secwatch.observer/filing/0000310764-24-000113.md","text":"https://secwatch.observer/filing/0000310764-24-000113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000113/0000310764-24-000113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000113/syk-20241029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:26:56.766894+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}